Español
Français
Deutsch
Italiano
Português
- Author:
- Eduardo Anitua
- Gorka Orive
- B de la Sen Corcuera
- R M Sánchez Ávila
- P Heredia
- F Muruzabal
- J Merayo-Lloves
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus
Expert Opin Biol Ther. 2022 Jan;22(1):31-45. The use of blood derivatives and especially Plasma rich in growth factors (PRGF), for regenerative purposes has been a common trend along the last decades in the field of oral surgery, dermatology, orthopedics, and more recently in ophthalmology.
- Author:
- Eduardo Anitua
- Ronald M Sánchez-Ávila
- Edmar Uribe-Badillo
- Carlos Fernández-Vega González
- Francisco Muruzabal
- Borja de la Sen-Corcuera
- Begoña Baamonde
- Luis M Quirós
- Jesús Merayo-Lloves
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
Vision (Basel). 2021 Jul 2;5(3):34. This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers
- Author:
- Eduardo Anitua
- Gorka Orive
Platelet-rich therapies as an emerging platform for regenerative medicine
Expert Opin Biol Ther. 2021 Dec;21(12):1603-1608. The combination of human plasma components with the multiple secretome from platelets has provided a new biological tool that is shaping a new future for its direct application in tissue regeneration as well as in cell culture and advanced therapy by means of its use as a clinical-grade supplement.
- Author:
- Eduardo Anitua
- Ronald M Sánchez-Ávila
- Natalia Vázquez
- Manuel Chacón
- Mairobi Persinal-Medina
- Agustín Brea-Pastor
- Silvia Berisa-Prado
- Luis Fernández-Vega-Cueto
- lvaro Meana
- Jesús Merayo-Lloves
Fibrin-Plasma Rich in Growth Factors Membrane for the Treatment of a Rabbit Alkali-Burn Lesion
Int J Mol Sci. 2021 May 25;22(11):5564. The purpose of this work is to describe the use of Fibrin-Plasma Rich in Growth Factors (PRGF) membranes for the treatment of a rabbit alkali-burn lesion
- Author:
- Eduardo Anitua
- Ander Pino
- Libe Aspe
- MaIsabel Martínez
- Adrian García
- Felipe Goñi
- María Troya
Anti-inflammatory effect of different PRGF formulations on cutaneous surface
J Tissue Viability. 2021 May;30(2):183-189. Cutaneous autoimmune and inflammatory diseases are a major burden of global disease and many lack effective treatments that can derive in different dermatoses like atopic dermatitis. Despite the increase prevalence and the high health-care costs worldwide, the heterogeniety and multifactoriality of these diseases mean that effective treatment options are scarce.
- Author:
- Eduardo Anitua
- Roberto Prado
Platelet-Rich Plasma for Chronic Plantar Fasciitis: as with any other treatment, a comprehensive protocol is necessary
J Foot Ankle Surg. 2021 Mar-Apr;60(2):428. In this appealing clinical trial, the authors compare the pain and functional outcomes of single injection of platelet-rich plasma (PRP), corticosteroids (CS), and placebo for the treatment of patients diagnosed with chronic plantar fasciitis
- Author:
- Eduardo Anitua
- Gorka Orive
- Alfonso L Sabater
- Hazem M Mousa
- Xavier Quinones
- Felipe Valenzuela
- Ronald Mauricio Sanchez Avila
- Jesús Merayo
- Victor L Perez
Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases
Int Ophthalmol. 2021 Jul;41(7):2347-2358. To evaluate the safety and efficacy of the surgical use of autologous plasma rich in growth factors fibrin membrane (mPRGF) in improving corneal wound healing and regeneration in a variety of complex ocular surface defects.
- Author:
- Eduardo Anitua
- María de la Fuente
- Francisco Muruzábal
- Jesús Merayo-Lloves
Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditions
Eur J Ophthalmol. 2021 Mar;31(2):354-360. The purpose of this study was to analyze the biological content and activity of freeze-dried plasma rich in growth factors eye drops after their storage at 4°C and at room temperature for 3 months with respect to fresh samples (time 0)
- Author:
- Eduardo Anitua
- Ander Pino
- Mar Zalduendo
Long-term stability of a novel platelet-rich plasma-based topical serum for cutaneous applications
J Cosmet Dermatol. 2021 Mar;20(3):854-861. Skin alterations are usually related to chronic diseases that demand sustained and long-term dosages; hence, it is pivotal that the stability of treatments is preserved. A novel storable and endogenous topical serum (ES) based on the patient's own blood has been recently developed
- Author:
- Eduardo Anitua
- María de la Fuente
- Francisco Muruzabal
- Jesús Merayo-Lloves
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology
Exp Eye Res. 2021 Feb:203:108402. To develop and characterize a new type of plasma rich in growth factors (PRGF) membrane for patients in which immune system is involved in the disease etiology